RESUMEN
Fifty heterosexual partners out of 50 patients (index cases) without confirmed or probable risk factors of parenteral transmission by HCV were studied from 1/1997 to 1/2001. The index cases were HCV Ab (+) (EIA 3rd Abbott and PCR + by RT-nested PCR). The couples with probable or confirmed risk factors of parenteral transmission were strictly excluded. No case of HCV infection was found, suggesting that sexual via wouldn't be a direct transmission of HCV
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Hepatitis C , Enfermedades Virales de Transmisión Sexual , Argentina , Hepatitis C , Reacción en Cadena de la Polimerasa , Prevalencia , Factores de Riesgo , Conducta Sexual , Parejas Sexuales , Enfermedades Virales de Transmisión Sexual , EspososRESUMEN
It is accepted that the practice of odontology implies a risk of BBV and HCV transmission but the study of does not. This work tries to determine the prevalence of HBv Ac and HCV Ac (by ELISA) in odontology students and whether there is any relation to the year of study and/or the presence of other risk factors. 188 students in their last three years of studies were investigated, all the participants filled out a clinical epidemiological form. 89 women (47.3%) and 99 men (52.7%), x age was 24.8. 50 (26.7%) had other risk factors. 160 (85.1%) fulfilled biosecurity norms and 40 (21.2%) had a labour accident. RESULTS: None of the analyzed sera were positive for HCV Ac (0%) and 1 was positive for HbcAc. CONCLUSION: The prevalence of HBv Ac and HCV Ac is extremely low with no relation to the year of study or any other risk factors
Asunto(s)
Humanos , Masculino , Femenino , Hepatitis B , Hepatitis C , Estudiantes de Odontología , Argentina , Ensayo de Inmunoadsorción Enzimática , Hepatitis B , Anticuerpos contra la Hepatitis B , Hepatitis C , Anticuerpos contra la Hepatitis C , Transmisión de Enfermedad Infecciosa de Paciente a Profesional , Prevalencia , Factores de Riesgo , Estudios SeroepidemiológicosRESUMEN
O autor faz comentarios sobre a associacao rifampicina + trimetoprim e ressalta a necessidade de melhor controle de lancamento de medicamentos no comercio, por parte dos orgaos oficiais